Iktos
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $16M
Investors
- 3
About Iktos
Based in Paris, France, and founded in 2016, Iktos provides artificial intelligence technology and software for ligand-based and structure-based de novo drug design. The company was co-founded by Yann Gaston-Mathe (CEO), Quentin Perron, and Nicolas Do Huu. The company offers deep learning-based de novo design for medicinal chemistry. Additionally, the firm has also developed Makya which is a SaaS application used for AI-driven de novo design. Furthermore, the also offers Spaya which is a computer-aided synthetic planning technology. Apart from this, Spaya API helps in assessing the synthetic feasibility of molecules.
Who invested in Iktos
3 investors across 1 round
See all investors in Iktos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 4, 2023
Amount
$16M
Investors
Questions about Iktos
Who invested in Iktos?
Iktos has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Iktos raised?
Iktos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Iktos last raise money?
Iktos's most recent round on record is a Series A, in Mar 2023.
What does Iktos do?
Based in Paris, France, and founded in 2016, Iktos provides artificial intelligence technology and software for ligand-based and structure-based de novo drug design.
Where is Iktos headquartered?
Iktos is headquartered in Paris, France.
Which VCs invest in companies like Iktos?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Iktos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Iktos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.